查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1140005

心臟康復市場：按產品類型按疾病類型按最終用戶：2021-2031 年全球機會分析和行業預測

Cardiac Rehabilitation Market By Product, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 269 Pages | 商品交期: 2-3個工作天內

價格

全球心臟康復市場預計將在 2021 年達到 19.711 億美元，在 2031 年達到 32.4138 億美元，從 2022 年到 2031 年的複合年增長率為 5.1%。

心臟康復是一項醫療管理計劃，旨在改善患者的心血管健康。為門診患者量身定制的鍛煉計劃。心臟康復通常包括運動訓練以降低患心髒病的風險。對於心髒病發作、心力衰竭、冠狀動脈旁路移植術和心臟瓣膜修復置換術的高風險患者來說，這一點很重要。心臟康復計劃旨在限制心血管疾病引起的心理壓力，改善心血管功能，使患者獲得最佳生活質量。心臟康復提供人們在日常生活中需要的有關心臟問題的信息。這些儀器/設備可用於心血管手術和心髒病發作的康復。

推動心臟康復市場增長的主要因素是心血管疾病病例數量的增加以及越來越多地採用遠程心臟康復以最大程度地減少時間、距離和成本的障礙。 .此外，許多因素正在推動市場增長，例如心臟康復設備的技術進步數量、這些治療的採用率不斷提高，以及對心臟相關疾病的早期干預和一級預防的日益重視。這裡。此外，在 COVID-19 大流行期間不斷增長的需求和採用指尖血氧計設備對患者進行持續監測，以及許多主要參與者推出新的指尖脈搏血氧計，這些都是推動市場增長的主要驅動因素。此外，根據經濟合作與發展組織的數據，2018 年德國共進行了 45,307 例冠狀動脈旁路移植術。因此，急診手術發病率的激增和術後心臟康復設備的廣泛使用推動了心臟康復市場的增長。

此外，醫藥和醫療器械行業的發展以及醫療成本的改善也有望推動心臟康復市場的增長。例如，2020 年 1 月，Omron Corporation推出了 HeartGuide 設備。該設備是一種監測血壓的可穿戴心臟康復產品。這使您可以隨時隨地監測您的血壓。此外，可以掌握白天的血壓波動，並用它來控制高血壓。定期進行血壓自我監測可以顯著降低患心髒病的風險。此外，由於美國的高需求和預購銷售，Omron Corporation已經申請了 80 多項專利，並將 HeartGuide 開發到手錶設計中，以確保准確性和可靠性。因此，創新產品線的存在正在推動心臟康復市場的增長。

此外，老年人口的增長和心血管疾病負擔的增加導致人們對心臟康復的認識提高，從而推動了市場的增長。此外，世界衛生組織估計，2019 年將有 1790 萬人死於心血管疾病。因此，預計心血管疾病負擔的激增和心力衰竭率的增加將推動對心臟康復的需求。此外，預計在預測期內，越來越多的產品批准將為全球市場的擴張提供獎勵機會。久坐不動的生活方式易患許多疾病，例如糖尿病和心血管疾病。高血壓和糖尿病是導致心力衰竭增加的兩個主要因素。由於住院率高以及頻繁使用心率和血壓監測設備，這種疾病代價高昂。因此，與慢性病增加相關的手術數量的增加預計將提高心臟康復產品的採用率並推動市場的增長率。

但是，預計心臟康復產品的高成本、有限的資金以及缺乏熟練的專業人員將阻礙市場增長。如今，人們的健康意識越來越強，這有望幫助他們保持健康並使用更多的家庭健身器材。結果，許多主要參與者進入了新興市場，為心臟康復市場提供了豐厚的增長機會。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概覽

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特五力分析
  • 主要公司的定位
  • 市場動態
    • 驅動程序
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章心臟康復市場：按產品分類

  • 概覽
    • 市場規模和預測
  • 橢圓機
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 穩定球
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 跑步機
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 心率監測器
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 血壓計
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 降低
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章心臟康復市場：按疾病類型分類

  • 概覽
    • 市場規模和預測
  • 經皮冠狀動脈介入治療
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：國家/地區分析
  • 心肌梗塞
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 冠狀動脈：旁路移植術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 冠狀動脈疾病
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章心臟康復市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 康復中心
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 醫院
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 醫務室
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 7 章心臟康復市場：按地區劃分

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機遇
    • 北美市場規模和預測：按產品分類
    • 北美市場規模和預測：按疾病類型
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機遇
    • 歐洲市場規模和預測：按產品分類
    • 歐洲市場規模和預測：按疾病類型
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機遇
    • 亞太市場規模和預測：按產品分類
    • 亞太地區市場規模和疾病類型預測
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • LAMEA
    • 主要趨勢和機遇
    • LAMEA 市場規模和預測：按產品分類
    • LAMEA 市場規模和預測：按疾病類型
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章企業情況

  • 簡介
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 競賽儀表板
  • 比賽熱圖
  • 主要發展

第 9 章公司簡介

  • Halma plc.
  • Life Fitness
  • GE Healthcare
  • Smiths Group
  • Koninklijke Philips N.V.
  • Omron Corporation
  • Technogym
  • Core Health & Fitness, LLC
  • Baxter
  • Johnson Health Tech.
Product Code: A11270

The global cardiac rehabilitation market was valued at $1,971.1 million in 2021 and is projected to reach $3,241.38 million by 2031 registering a CAGR of 5.1% from 2022 to 2031.

Cardiac rehab is a medically supervised program which is designed to improve patient's cardiovascular health. It is customized outpatient program of exercise. Cardiac rehabilitation often involves exercise training to reduce heart disease risk. It is important for patients who are at higher risk of heart attack, heart failure, coronary artery bypass graft, and heart valve repair replacement. Cardiac rehabilitation program aims to limit the psychological stresses of cardiovascular disease and improve cardiovascular function to help patients achieve their highest quality of life possible. Cardiac rehab gives the information which is required in everyday life about heart disorders. These equipment/devices help recover from cardiovascular surgery and heart attack.

The main factors that foster the growth of the cardiac rehabilitation market are rise in cases of cardiovascular disease, and increase in adoption of tele-cardiac rehabilitation to minimize barriers for time, distance and cost. Along with this, a number of factors such as a large number of technological advancements in cardiac rehab devices, increase in adoption rate of these therapies, and rise in emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market growth. Moreover, rise in demand and adoption of finger-tip oximeter devices during the COVID-19 pandemic for continuous patient monitoring and launch of new finger-tip pulse oximeter by large number of key players are the major factors driving the market growth. Furthermore, as per Organization for Economic Co-operation and Development, in 2018, a total of 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the surge in incidences of emergency surgeries and extensive uses of cardiac rehabilitation devices post-surgery propel the growth of the cardiac rehabilitation market.

Moreover, development of pharmaceutical & medical device industries and improvement in healthcare spending are anticipated to drive the growth of the cardiac rehabilitation market. For instance, in January 2020, Omron Corporation has launched HeartGuide device. This device is a wearable cardiac rehabilitation product that monitor blood pressure. It enabled people to monitor their blood pressure wherever and whenever they want. It also helps to understand the fluctuation of blood pressure in day time and helps to get control over high blood pressure. Regular self-monitoring of blood pressure can significantly reduce the risk of cardiac disorders. Moreover, high demand from the U.S. and pre-order availability for HeartGuide led Omron to file more than 80 patents to develop HeartGuide in the design of wrist watch that ensures the accuracy and reliability. Thus, presence of innovative product lines fuels the growth of the cardiac rehabilitation market.

Furthermore, rise in geriatric population and increase in burden of cardiovascular diseases lead to rise in awareness regarding cardiac rehabilitation among people, which drive the growth of the market. Moreover, according to World Health Organization, 17.9 million people were estimated to die from cardiovascular disease in 2019. Thus, upsurge in burden of cardiovascular diseases and increased rate of heart failure are anticipated to boost the demand for cardiac rehabilitation. Furthermore, rise in number of product approvals is expected to provide remunerative opportunities for the expansion of the global market during the forecast period. Sedentary lifestyle makes people susceptible to having many disorders such as diabetes, and cardiovascular disorders. High blood pressure and diabetes are the two main factors responsible for the rise in number of heart failures. This disease is associated with high hospitalization rate and substantial cost due to frequent use of heart rate and blood pressure monitor devices. Thus, an increase in number of surgeries due to rise in cases of chronic diseases is expected to increase the adoption rate of cardiac rehabilitation products and increase the growth of the market.

However, high costs of cardiac rehabilitation products, limited availability of funds, and dearth of skilled professionals are the factors projected to impede the market growth. Presently, there is an increase in awareness regarding health among people, which, in turn, compels them to maintain their health condition and leads to rise in usage of home fitness devices. This has encouraged many key players to enter emerging market, thus offering lucrative growth opportunities in the cardiac rehabilitation market.

For the purpose of analysis cardiac rehabilitation market is studied across by product type, disease type, and end user. On the basis of product type the market is segmented into elliptical trainer, stabilization ball, treadmills, heart rate monitor, blood pressure monitor, rower, and others. By disease type, the market is divided into percutaneous coronary intervention, myocardial infraction, coronary artery bypass grafting, coronary artery disease, and others. By end user, it is categorized into rehab centers, hospitals, clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players mentioned in the report are Baxter International Inc., Core Health & Fitness, LLC, GE Healthcare, Halma Plc, Johnson Health Tech, Koninklijke Philips N.V, Life Fitness, Omron Corporation, Smith Group, and Technogym.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiac rehabilitation market analysis from 2021 to 2031 to identify the prevailing cardiac rehabilitation market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cardiac rehabilitation market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cardiac rehabilitation market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Elliptical Trainer
  • Stabilization ball
  • Treadmill
  • Heart rate monitor
  • Blood pressure monitor
  • Rower
  • Others

By Disease Type

  • Percutaneous Coronary Intervention
  • Myocardial Infarction
  • Coronary Artery Bypass Grafting
  • Coronary Artery Disease
  • Others

By End User

  • Rehab Centers
  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Halma plc.
    • Life Fitness
    • GE Healthcare
    • Smiths Group
    • Koninklijke Philips N.V.
    • Omron Corporation
    • Technogym
    • Core Health & Fitness, LLC
    • Baxter
    • Johnson Health Tech.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CARDIAC REHABILITATION MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Elliptical Trainer
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Stabilization ball
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Treadmill
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Heart rate monitor
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Blood pressure monitor
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country
  • 4.7 Rower
    • 4.7.1 Key market trends, growth factors and opportunities
    • 4.7.2 Market size and forecast, by region
    • 4.7.3 Market analysis by country
  • 4.8 Others
    • 4.8.1 Key market trends, growth factors and opportunities
    • 4.8.2 Market size and forecast, by region
    • 4.8.3 Market analysis by country

CHAPTER 5: CARDIAC REHABILITATION MARKET, BY DISEASE TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Percutaneous Coronary Intervention
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Myocardial Infarction
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Coronary Artery Bypass Grafting
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Coronary Artery Disease
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country
  • 5.6 Others
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market analysis by country

CHAPTER 6: CARDIAC REHABILITATION MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Rehab Centers
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Hospitals
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Clinics
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5 Others
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country

CHAPTER 7: CARDIAC REHABILITATION MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
    • 7.2.3 North America Market size and forecast, by Disease Type
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Disease Type
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Disease Type
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Disease Type
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.3 Europe Market size and forecast, by Disease Type
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Disease Type
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Disease Type
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 U.K.
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Disease Type
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Disease Type
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Product
      • 7.3.5.5.2 Market size and forecast, by Disease Type
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Product
      • 7.3.5.6.2 Market size and forecast, by Disease Type
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.3 Asia-Pacific Market size and forecast, by Disease Type
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Disease Type
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Disease Type
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Disease Type
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Disease Type
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Disease Type
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Product
      • 7.4.5.6.2 Market size and forecast, by Disease Type
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.3 LAMEA Market size and forecast, by Disease Type
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Disease Type
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Disease Type
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Disease Type
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Disease Type
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Halma plc.
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Life Fitness
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 GE Healthcare
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Smiths Group
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Koninklijke Philips N.V.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Omron Corporation
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Technogym
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Core Health & Fitness, LLC
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Baxter
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Johnson Health Tech.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. CARDIAC REHABILITATION MARKET SIZE, FOR ELLIPTICAL TRAINER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. CARDIAC REHABILITATION MARKET FOR ELLIPTICAL TRAINER BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. CARDIAC REHABILITATION MARKET SIZE, FOR STABILIZATION BALL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. CARDIAC REHABILITATION MARKET FOR STABILIZATION BALL BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. CARDIAC REHABILITATION MARKET SIZE, FOR TREADMILL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. CARDIAC REHABILITATION MARKET FOR TREADMILL BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. CARDIAC REHABILITATION MARKET SIZE, FOR HEART RATE MONITOR, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. CARDIAC REHABILITATION MARKET FOR HEART RATE MONITOR BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. CARDIAC REHABILITATION MARKET SIZE, FOR BLOOD PRESSURE MONITOR, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. CARDIAC REHABILITATION MARKET FOR BLOOD PRESSURE MONITOR BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. CARDIAC REHABILITATION MARKET SIZE, FOR ROWER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. CARDIAC REHABILITATION MARKET FOR ROWER BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. CARDIAC REHABILITATION MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. CARDIAC REHABILITATION MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. GLOBAL CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 17. CARDIAC REHABILITATION MARKET SIZE, FOR PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. CARDIAC REHABILITATION MARKET FOR PERCUTANEOUS CORONARY INTERVENTION BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 19. CARDIAC REHABILITATION MARKET SIZE, FOR MYOCARDIAL INFARCTION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. CARDIAC REHABILITATION MARKET FOR MYOCARDIAL INFARCTION BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. CARDIAC REHABILITATION MARKET SIZE, FOR CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. CARDIAC REHABILITATION MARKET FOR CORONARY ARTERY BYPASS GRAFTING BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. CARDIAC REHABILITATION MARKET SIZE, FOR CORONARY ARTERY DISEASE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. CARDIAC REHABILITATION MARKET FOR CORONARY ARTERY DISEASE BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. CARDIAC REHABILITATION MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. CARDIAC REHABILITATION MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. GLOBAL CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 28. CARDIAC REHABILITATION MARKET SIZE, FOR REHAB CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 29. CARDIAC REHABILITATION MARKET FOR REHAB CENTERS BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. CARDIAC REHABILITATION MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 31. CARDIAC REHABILITATION MARKET FOR HOSPITALS BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. CARDIAC REHABILITATION MARKET SIZE, FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 33. CARDIAC REHABILITATION MARKET FOR CLINICS BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 34. CARDIAC REHABILITATION MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 35. CARDIAC REHABILITATION MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 36. CARDIAC REHABILITATION MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 37. NORTH AMERICA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 38. NORTH AMERICA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 39. NORTH AMERICA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. NORTH AMERICA CARDIAC REHABILITATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 41. U.S. CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 42. U.S. CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 43. U.S. CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. CANADA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 45. CANADA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 46. CANADA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 47. MEXICO CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 48. MEXICO CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 49. MEXICO CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 50. EUROPE CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 51. EUROPE CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 52. EUROPE CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. EUROPE CARDIAC REHABILITATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 54. GERMANY CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 55. GERMANY CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 56. GERMANY CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. FRANCE CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 58. FRANCE CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 59. FRANCE CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 60. U.K. CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 61. U.K. CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 62. U.K. CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 63. ITALY CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 64. ITALY CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 65. ITALY CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 66. SPAIN CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 67. SPAIN CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 68. SPAIN CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 69. REST OF EUROPE CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 70. REST OF EUROPE CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 71. REST OF EUROPE CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 73. ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 74. ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 75. ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 76. JAPAN CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 77. JAPAN CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 78. JAPAN CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 79. CHINA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 80. CHINA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 81. CHINA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 82. AUSTRALIA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 83. AUSTRALIA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 84. AUSTRALIA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 85. INDIA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 86. INDIA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 87. INDIA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 88. SOUTH KOREA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 89. SOUTH KOREA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 90. SOUTH KOREA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 96. LAMEA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 97. LAMEA CARDIAC REHABILITATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 98. BRAZIL CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 99. BRAZIL CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 100. BRAZIL CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 101. SAUDI ARABIA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 102. SAUDI ARABIA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 103. SAUDI ARABIA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 104. SOUTH AFRICA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 105. SOUTH AFRICA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 106. SOUTH AFRICA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 107. REST OF LAMEA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 108. REST OF LAMEA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
  • TABLE 109. REST OF LAMEA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 110.HALMA PLC.: COMPANY SNAPSHOT
  • TABLE 111.HALMA PLC.: OPERATING SEGMENTS
  • TABLE 112.HALMA PLC.: PRODUCT PORTFOLIO
  • TABLE 113.HALMA PLC.: NET SALES,
  • TABLE 114.HALMA PLC.: KEY STRATERGIES
  • TABLE 115.LIFE FITNESS: COMPANY SNAPSHOT
  • TABLE 116.LIFE FITNESS: OPERATING SEGMENTS
  • TABLE 117.LIFE FITNESS: PRODUCT PORTFOLIO
  • TABLE 118.LIFE FITNESS: NET SALES,
  • TABLE 119.LIFE FITNESS: KEY STRATERGIES
  • TABLE 120.GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 121.GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 122.GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 123.GE HEALTHCARE: NET SALES,
  • TABLE 124.GE HEALTHCARE: KEY STRATERGIES
  • TABLE 125.SMITHS GROUP: COMPANY SNAPSHOT
  • TABLE 126.SMITHS GROUP: OPERATING SEGMENTS
  • TABLE 127.SMITHS GROUP: PRODUCT PORTFOLIO
  • TABLE 128.SMITHS GROUP: NET SALES,
  • TABLE 129.SMITHS GROUP: KEY STRATERGIES
  • TABLE 130.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 131.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
  • TABLE 132.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 133.KONINKLIJKE PHILIPS N.V.: NET SALES,
  • TABLE 134.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
  • TABLE 135.OMRON CORPORATION: COMPANY SNAPSHOT
  • TABLE 136.OMRON CORPORATION: OPERATING SEGMENTS
  • TABLE 137.OMRON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 138.OMRON CORPORATION: NET SALES,
  • TABLE 139.OMRON CORPORATION: KEY STRATERGIES
  • TABLE 140.TECHNOGYM: COMPANY SNAPSHOT
  • TABLE 141.TECHNOGYM: OPERATING SEGMENTS
  • TABLE 142.TECHNOGYM: PRODUCT PORTFOLIO
  • TABLE 143.TECHNOGYM: NET SALES,
  • TABLE 144.TECHNOGYM: KEY STRATERGIES
  • TABLE 145.CORE HEALTH & FITNESS, LLC: COMPANY SNAPSHOT
  • TABLE 146.CORE HEALTH & FITNESS, LLC: OPERATING SEGMENTS
  • TABLE 147.CORE HEALTH & FITNESS, LLC: PRODUCT PORTFOLIO
  • TABLE 148.CORE HEALTH & FITNESS, LLC: NET SALES,
  • TABLE 149.CORE HEALTH & FITNESS, LLC: KEY STRATERGIES
  • TABLE 150.BAXTER: COMPANY SNAPSHOT
  • TABLE 151.BAXTER: OPERATING SEGMENTS
  • TABLE 152.BAXTER: PRODUCT PORTFOLIO
  • TABLE 153.BAXTER: NET SALES,
  • TABLE 154.BAXTER: KEY STRATERGIES
  • TABLE 155.JOHNSON HEALTH TECH.: COMPANY SNAPSHOT
  • TABLE 156.JOHNSON HEALTH TECH.: OPERATING SEGMENTS
  • TABLE 157.JOHNSON HEALTH TECH.: PRODUCT PORTFOLIO
  • TABLE 158.JOHNSON HEALTH TECH.: NET SALES,
  • TABLE 159.JOHNSON HEALTH TECH.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CARDIAC REHABILITATION MARKET SEGMENTATION
  • FIGURE 2.CARDIAC REHABILITATION MARKET,2021-2031
  • FIGURE 3.CARDIAC REHABILITATION MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CARDIAC REHABILITATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.CARDIAC REHABILITATION MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ELLIPTICAL TRAINER CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF STABILIZATION BALL CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF TREADMILL CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HEART RATE MONITOR CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF BLOOD PRESSURE MONITOR CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ROWER CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 20.CARDIAC REHABILITATION MARKET,BY DISEASE TYPE,2021(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF PERCUTANEOUS CORONARY INTERVENTION CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF MYOCARDIAL INFARCTION CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTING CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY DISEASE CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 26.CARDIAC REHABILITATION MARKET,BY END USER,2021(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF REHAB CENTERS CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF CLINICS CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC REHABILITATION MARKET,2021-2031(%)
  • FIGURE 31.CARDIAC REHABILITATION MARKET BY REGION,2021
  • FIGURE 32.U.S. CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 33.CANADA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 34.MEXICO CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 35.GERMANY CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 36.FRANCE CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 37.U.K. CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 38.ITALY CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 39.SPAIN CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF EUROPE CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 41.JAPAN CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 42.CHINA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 43.AUSTRALIA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 44.INDIA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 45.SOUTH KOREA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 46.REST OF ASIA-PACIFIC CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 47.BRAZIL CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 48.SAUDI ARABIA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 49.SOUTH AFRICA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 50.REST OF LAMEA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
  • FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 54.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 55.COMPETITIVE DASHBOARD
  • FIGURE 56.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 57.HALMA PLC..: NET SALES ,($MILLION)
  • FIGURE 58.LIFE FITNESS.: NET SALES ,($MILLION)
  • FIGURE 59.GE HEALTHCARE.: NET SALES ,($MILLION)
  • FIGURE 60.SMITHS GROUP.: NET SALES ,($MILLION)
  • FIGURE 61.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
  • FIGURE 62.OMRON CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 63.TECHNOGYM.: NET SALES ,($MILLION)
  • FIGURE 64.CORE HEALTH & FITNESS, LLC.: NET SALES ,($MILLION)
  • FIGURE 65.BAXTER.: NET SALES ,($MILLION)
  • FIGURE 66.JOHNSON HEALTH TECH..: NET SALES ,($MILLION)